These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29414323)

  • 1. Letter to Yokoyama et al. (Yokoyama Y. Cytokine. 2017 Dec 29; 103: 25-28).
    Rodríguez-Lago I; Cabriada JL
    Cytokine; 2018 Apr; 104():29. PubMed ID: 29414323
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy and safety of selective granulocyte and monocyte apheresis for inflammatory bowel disease: A meta-analysis.
    Liu Z; Jiang X; Sun C
    Eur J Intern Med; 2016 Dec; 36():e26-e27. PubMed ID: 27614377
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.
    Nesbitt A; Fossati G; Bergin M; Stephens P; Stephens S; Foulkes R; Brown D; Robinson M; Bourne T
    Inflamm Bowel Dis; 2007 Nov; 13(11):1323-32. PubMed ID: 17636564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis.
    Furusawa K; Hasegawa T; Ikeda S
    Ther Apher Dial; 2012 Aug; 16(4):379-80. PubMed ID: 22817129
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study.
    Di Girolamo M; Sartini A; Critelli R; Bertani A; Merighi A; Villa E
    Ther Apher Dial; 2016 Dec; 20(6):668-676. PubMed ID: 27921374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action.
    Mitsuyama K; Sata M
    Cytotherapy; 2009; 11(2):229-37. PubMed ID: 19241197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.
    Lügering N; Kucharzik T; Stoll R; Domschke W
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):338-44. PubMed ID: 9759608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
    Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
    Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Sáez-González E; Moret I; Alvarez-Sotomayor D; Díaz-Jaime FC; Cerrillo E; Iborra M; Nos P; Beltrán B
    Dig Dis Sci; 2017 Jun; 62(6):1417-1425. PubMed ID: 28432476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Temperature on Granulocyte and Monocyte Adsorption to Cellulose Acetate Beads.
    Nishise S; Takeda Y; Abe Y; Sasaki Y; Nara H; Asao H; Ueno Y
    Ther Apher Dial; 2017 Jun; 21(3):248-254. PubMed ID: 28661094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions.
    Srinivas NR
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1133. PubMed ID: 26427755
    [No Abstract]   [Full Text] [Related]  

  • 13. A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy.
    Kuwaki K; Mitsuyama K; Kaida H; Takedatsu H; Yoshioka S; Yamasaki H; Yamauchi R; Fukunaga S; Abe T; Tsuruta O; Torimura T
    Cytotherapy; 2016 Feb; 18(2):291-9. PubMed ID: 26700210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives.
    Vernia P; D'Ovidio V; Meo D
    Transfus Apher Sci; 2010 Oct; 43(2):227-9. PubMed ID: 20817610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions. Authors' reply.
    Buurman DJ; Maurer JM; Keizer RJ; Kosterink JG; Dijkstra G
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1134. PubMed ID: 26427756
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte and monocyte adsorptive apheresis in the management of ulcerative colitis.
    Yamamoto T
    Aliment Pharmacol Ther; 2011 Jan; 33(2):288; author reply 289. PubMed ID: 21155856
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis.
    Kanekura T; Mochitomi Y; Fujimoto S; Kawahara K; Maruyama I; Kanzaki T
    J Am Acad Dermatol; 2005 Jun; 52(6):1108-9. PubMed ID: 15928646
    [No Abstract]   [Full Text] [Related]  

  • 18. Granulocyte/monocyte apheresis as immunotherapic tool: cellular adsorption and immune modulation.
    Cuadrado E
    Autoimmun Rev; 2009 Feb; 8(4):292-6. PubMed ID: 18804557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of mucosal healing by intensive granulocyte and monocyte adsorptive aphaeresis in active ulcerative colitis patients without concomitant corticosteroid therapy.
    Fukuchi T; Nakase H; Ito D; Yamashita H; Matsuura M; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Otzuka M; Ashida K
    Aliment Pharmacol Ther; 2011 Sep; 34(5):583-5. PubMed ID: 21806645
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection.
    Nakase H; Matsuura M; Chiba T
    Aliment Pharmacol Ther; 2011 Feb; 33(4):497-8; author reply 498. PubMed ID: 21235601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.